Abbott India Limited
ABBOTINDIA
Peringkat dalam Saham
#3023
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Harga Saham
$284.73
Terakhir disinkronkan: 2026-10-21
Kapitalisasi Pasar
$6.05B
Perubahan (1 hari)
-0.41%
Perubahan (1 tahun)
-17.16%
Negara
IN
Perdagangan Abbott India Limited (ABBOTINDIA)
Kategori
Healthcare
Pendapatan untuk Abbott India Limited (ABBOTINDIA)
Pendapatan pada Jun 2026 TTM: $772.99M
Menurut laporan keuangan terbaru dari Abbott India Limited, pendapatan saat ini (TTM) adalah $772.99M. Pada tahun 2024, perusahaan menghasilkan pendapatan sebesar $701.24M peningkatan dibandingkan pendapatan pada tahun 2023 yang sebesar $650.61M. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Abbott India Limited dari 2004 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $772.99M | 3.15% |
| 2025 | $749.38M | 6.86% |
| 2024 | $701.24M | 7.78% |
| 2023 | $650.61M | 0.58% |
| 2022 | $646.86M | 9.93% |
| 2021 | $588.44M | 8.35% |
| 2020 | $543.07M | 2.60% |
| 2019 | $529.31M | 4.42% |
| 2018 | $506.91M | 13.64% |
| 2017 | $446.07M | 14.62% |
| 2016 | $389.18M | 8.61% |
| 2015 | $358.32M | 14.89% |
| 2014 | $311.88M | 6.42% |
| 2012 | $293.06M | 7.73% |
| 2011 | $272.03M | 22.82% |
| 2010 | $221.48M | 35.16% |
| 2009 | $163.87M | 22.44% |
| 2008 | $133.84M | -10.95% |
| 2007 | $150.29M | 31.48% |
| 2006 | $114.30M | 17.96% |
| 2005 | $96.90M | 6.51% |
| 2004 | $90.98M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $79.67B | 10,206.12% |
US
|
|
| $99.34B | 12,750.67% |
US
|
|
| $64.39B | 8,229.42% |
US
|
|
| $66.40B | 8,489.97% |
US
|
|
| $77.52B | 9,928.34% |
CH
|
